US Broker Ratings

RadNet, Inc. (RDNT) Stock Analysis: Exploring a Potential 35% Upside in the Diagnostics & Research Sector

RadNet, Inc. (NASDAQ: RDNT) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $5.5 billion, RadNet is a..

Sanofi (SNY) Stock Analysis: Promising 34.57% Upside Amid Robust Dividend Yield

Sanofi (SNY), a titan in the healthcare sector, is attracting investor attention with a potential upside of 34.57% and a noteworthy dividend yield of 6.06%. As a leading player in..

Encompass Health Corporation (EHC) Stock Analysis: Evaluating a 23.68% Upside Potential

Encompass Health Corporation (NYSE: EHC) stands as a robust player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $11.82 billion, this Birmingham,..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Unveiling a 28.41% Potential Upside in Biotech

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, is attracting attention from investors seeking substantial growth potential. The company, with a robust market capitalization of $8.31..

Merck & Company, Inc. (MRK) Stock Analysis: Evaluating Its 7.94% Potential Upside

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, continues to be a focal point for investors with its robust pharmaceutical and veterinary product lines. With a..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A Potential 23.85% Upside for Healthcare Investors

Investors with an eye on healthcare stocks should take a closer look at Smith & Nephew SNATS, Inc. (SNN), a formidable player in the medical devices industry. With a robust..

Grifols, S.A. (GRFS) Stock Analysis: Is a 48.63% Potential Upside Within Reach for This Healthcare Giant?

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector, is an intriguing stock for investors seeking exposure to the drug manufacturing industry. With a market capitalization of $4.98..

Biogen Inc. (BIIB) Stock Analysis: Assessing a 8.32% Potential Upside for Strategic Investors

Biogen Inc. (NASDAQ: BIIB) has been a stalwart in the healthcare sector, specifically in the realm of drug manufacturing. With a market capitalization of $32.49 billion, Biogen stands as a..

Fresenius Medical Care AG (FMS) Stock Analysis: Exploring the 5.41% Potential Upside in Healthcare

Fresenius Medical Care AG (FMS), a prominent player in the healthcare sector specializing in medical care facilities, is drawing investor interest as it navigates the complexities of the global dialysis..

HCA Healthcare, Inc. (HCA) Stock Analysis: 6.45% Potential Upside and Strong Buy Ratings

For investors eyeing the healthcare sector, HCA Healthcare, Inc. (NYSE: HCA) stands out as a significant player with its expansive network of medical care facilities. With a substantial market capitalization..

Repligen Corporation (RGEN)

⚠️ No article content returned.

..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating the Healthcare Tech Frontier with a $13.83 Billion Market Cap

Tempus AI, Inc. (NASDAQ: TEM) is making waves in the healthcare technology sector, focusing on integrating cutting-edge artificial intelligence with health information services. With a current market capitalization of $13.83..

Corcept Therapeutics (CORT) Stock Analysis: A 21% Upside Potential in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) stands out in the biotechnology sector with a compelling growth narrative, driven by its innovative treatments for severe endocrinologic, oncologic, metabolic, and neurologic disorders. Headquartered..

STERIS plc (STE) Stock Analysis: Navigating a 26% Potential Upside in Healthcare Innovation

STERIS plc (NYSE: STE), a leader in the healthcare sector focusing on infection prevention solutions, presents a compelling opportunity for investors, particularly with a substantial potential upside of 26.17%. With..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 10.23% Potential Upside for Investors

Investors eyeing opportunities within the healthcare sector may find Viatris Inc. (VTRS) an intriguing prospect, particularly given its current valuation and analyst projections. With a market capitalization of $20.22 billion,..

AptarGroup, Inc. (ATR) Stock Analysis: Potential 41.89% Upside with Strong Buy Ratings

AptarGroup, Inc. (NYSE: ATR), a key player in the healthcare sector, offers investors a compelling opportunity with its robust market position and potential for significant upside. With a market capitalization..

Revvity, Inc. (RVTY) Stock Analysis: Navigating a Healthcare Giant’s Potential Amidst Mixed Ratings

Revvity, Inc. (NYSE: RVTY) has emerged as a notable player within the healthcare sector, specifically in diagnostics and research. With a robust market capitalization of $16.91 billion, the company stands..

Elanco Animal Health (ELAN) Stock Analysis: Potential 40% Upside Captivates Investor Interest

For investors with an eye on the healthcare sector, Elanco Animal Health Incorporated (NYSE: ELAN) offers a compelling investment opportunity in the drug manufacturing space, particularly for those interested in..

Globus Medical, Inc. (GMED) Stock Analysis: A Promising 33.50% Upside in the Healthcare Sector

Globus Medical, Inc. (NYSE: GMED), a key player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with a potential upside of 33.50%. With its market..

Quest Diagnostics (DGX) Stock Report: Evaluating a Potential 6.17% Upside in the Diagnostics Giant

As investors continue to navigate the ever-evolving landscape of the healthcare sector, Quest Diagnostics Incorporated (NYSE: DGX) stands out as a key player in diagnostics and research. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds